Answers are grounded in this paper and cite their sources.
New insights show endogenous DNA damage affects mutation risk in humans, suggesting implications for disease management.
Endogenous DNA damage from metabolism and genome dynamics drives mutation, instability, and disease. New insights from ACS Fall 2025 reveal chemical diversity, metabolic drivers, and repair limits that shape cancer risk and biomarker development.
No takes yet. Share an insight, caveat, or question.
Bryan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: